Arrowstreet Capital, Limited Partnership Durect Corp Transaction History

Arrowstreet Capital, Limited Partnership

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.65 - $2.43 $992,412 - $1.46 Million	-601,462 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$1.6 - $2.35 $104,265 - $153,140	65,166 Added 12.15%	601,462 $1.03 Million
Q2 2020 Aug 12, 2020	BUY	$1.33 - $2.76 $374,896 - $777,980	281,877 Added 110.79%	536,296 $1.24 Million
Q1 2020 May 15, 2020	BUY	$0.97 - $2.85 $246,786 - $725,094	254,419 New	254,419 $394,000
Q3 2018 Nov 14, 2018	SELL	$1.06 - $1.69 $74,861 - $119,354	-70,624 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.56 - $2.51 $110,173 - $177,266	70,624 New	70,624 $110,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $175M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.